Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Calais

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
European Urology Oncology|February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 StudyDavid Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
The Lancet. Oncology|January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised studyJean-François Bosset, Gilles Calais, Laurent Mineur, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)René-Jean Bensadoun, Karen Bénézery, Olivier Dassonville, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2019
Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUGDavid Pasquier, Geoffrey Martinage, Guillaume Janoray, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 29, 2008
Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvementSéverine Racadot, Mariette Mercier, Sophie Dussart, et al.
European Urology|August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 TrialNicolas Demogeot, Paul Sargos, Julia Salleron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II studyJean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, et al.
The Lancet. Oncology|January 21, 2012
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialJean Bourhis, Christian Sire, Pierre Graff, et al.
Bulletin Du Cancer|February 28, 2024
[French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment]Béatrix Barry, Gilles Dolivet, Florian Clatot, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
European Urology Oncology|February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 StudyDavid Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
The Lancet. Oncology|January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised studyJean-François Bosset, Gilles Calais, Laurent Mineur, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)René-Jean Bensadoun, Karen Bénézery, Olivier Dassonville, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2019
Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUGDavid Pasquier, Geoffrey Martinage, Guillaume Janoray, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 29, 2008
Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvementSéverine Racadot, Mariette Mercier, Sophie Dussart, et al.
European Urology|August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 TrialNicolas Demogeot, Paul Sargos, Julia Salleron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II studyJean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, et al.
The Lancet. Oncology|January 21, 2012
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialJean Bourhis, Christian Sire, Pierre Graff, et al.
Bulletin Du Cancer|February 28, 2024
[French national standard for the treatment of squamous cell carcinoma of upper aero-digestive tract - General principles of treatment]Béatrix Barry, Gilles Dolivet, Florian Clatot, et al.
Pageof 6